ZNF195 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.949620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.465000E-01
Normal-vs-Stage2
1.860640E-01
Normal-vs-Stage3
2.925600E-01
Normal-vs-Stage4
6.760000E-01
Stage1-vs-Stage2
8.211800E-01
Stage1-vs-Stage3
5.773000E-01
Stage1-vs-Stage4
3.816800E-01
Stage2-vs-Stage3
5.955200E-01
Stage2-vs-Stage4
3.143200E-01
Stage3-vs-Stage4
3.327600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.110200E-01
Normal-vs-AfricanAmerican
1.367640E-01
Normal-vs-Asian
3.074000E-01
Caucasian-vs-AfricanAmerican
6.665400E-01
Caucasian-vs-Asian
9.141800E-01
AfricanAmerican-vs-Asian
7.843800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.155000E-01
Normal-vs-Female
1.893560E-01
Male-vs-Female
7.519600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.755600E-01
Normal-vs-Age(41-60Yrs)
2.278000E-01
Normal-vs-Age(61-80Yrs)
1.909040E-01
Normal-vs-Age(81-100Yrs)
2.514400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.847200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.690600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.624400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.433200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.614600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.288800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.913600E-01
Normal-vs-Daily Drinker
1.209610E-01
Normal-vs-Weekly Drinker
2.401000E-01
Normal-vs-Occasional Drinker
7.634600E-01
Normal-vs-Social Drinker
5.996400E-02
Non Drinker-vs-Daily Drinker
3.599600E-01
Non Drinker-vs-Weekly Drinker
5.538800E-01
Non Drinker-vs-Occasional Drinker
2.491600E-01
Non Drinker-vs-Social Drinker
5.424400E-01
Daily Drinker-vs-Weekly Drinker
8.716000E-01
Daily Drinker-vs-Occasional Drinker
3.841700E-02
Daily Drinker-vs-Social Drinker
6.564600E-01
Weekly Drinker-vs-Occasional Drinker
1.223210E-01
Weekly Drinker-vs-Social Drinker
8.500200E-01
Occasional Drinker-vs-Social Drinker
7.045700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.416400E-02
Normal-vs-Grade 2
3.775700E-03
Normal-vs-Grade 3
1.017700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.011400E-01
Grade 1-vs-Grade 3
3.469200E-01
Grade 1-vs-Grade 4
8.416400E-02
Grade 2-vs-Grade 3
9.129000E-01
Grade 2-vs-Grade 4
3.775700E-03
Grade 3-vs-Grade 4
1.017700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.058200E-01
Normal-vs-NonDiabetic
2.064000E-01
Diabetic-vs-NonDiabetic
4.376000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.796230E-01
Normal-vs-NoPancreatitis
1.985600E-01
Pancreatitis-vs-NoPancreatitis
7.304800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.614000E-01
Normal-vs-N1
1.637440E-01
N0-vs-N1
2.314200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.411600E-01
Normal-vs-TP53-NonMutant
4.138800E-01
TP53-Mutant-vs-TP53-NonMutant
5.114200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
